Business / Finance

RSS

MRO announces Keystone acquisition

MRO Corp., a leading provider of disclosure management applications and services for healthcare organizations, today announced that it has acquired the assets of Keystone Management Solutions, a provider of release of information services based in Malvern, Pennsylvania. This acquisition will enable MRO to continue building its market presence across Pennsylvania, Massachusetts and Louisiana, where Keystone Management Solutions currently serves hospitals and health systems.

18 Apr 2011

Pharma Tech expands agreement for Shasta Genstrip

InstaCare Corp. a leading provider of prescription diagnostics, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e-health products and technologies, today announced that its operating subsidiary, Pharma Tech Solutions, Inc., has significantly expanded its agreement to control, manage and distribute the novel at-home diagnostic product, the Shasta Genstrip.

18 Apr 2011

ARCA biopharma to sell $3 million of common stock and warrants in registered direct offering

ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation, heart failure and other cardiovascular diseases, today announced that it has agreed to sell approximately $3 million of its common stock and warrants to institutional investors in a registered direct offering.

18 Apr 2011

Symphony Technology Group acquires ImpactRx

ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced today that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies. Merck Capital Ventures (MCV), the venture capital arm of Merck and one of ImpactRx's existing investors, will maintain its investment in ImpactRx.

18 Apr 2011

Emerald Dairy fourth quarter total revenue increases 10.0% to 14.8 million

Emerald Dairy, Inc. a leading producer and distributor of infant and children's formula products, today announced financial results for its fourth quarter ended December 31, 2010.

18 Apr 2011

Double Eagle acquires Fuse Science

Double Eagle Holdings, Ltd. announced today that it has successfully completed the acquisition of Fuse Science, Inc. Under the terms of the acquisition agreement, Fuse Science becomes a wholly-owned subsidiary of Double Eagle, effectively repositioning Double Eagle as an innovation-based consumer products holding company.

18 Apr 2011

CoDa Therapeutics raises $19.2 million in Series B financing

CoDa Therapeutics, Inc. announced today that it has raised $19.2 million in a Series B financing. Current investors Domain Associates, GBS Venture Partners and BioPacificVentures participated in the round. The company expects further Series B financing with participation from additional investors in a second closing, scheduled for a future date.

18 Apr 2011

Amedisys enters agreement to acquire Beacon Hospice

Amedisys, Inc., one of America's leading home health and hospice companies, today announced it has signed a definitive agreement to acquire Beacon Hospice, Inc.

18 Apr 2011

Community Health Systems announces new $6.00 per share cash offer for Tenet

Community Health Systems, Inc. today announced that it is now offering $6.00 per share in cash to acquire all outstanding shares of Tenet Healthcare Corporation. The previous CHS offer was for $5.00 per share in cash and $1.00 per share in CHS common stock. The new offer was made in a letter to Tenet's Board of Directors today.

18 Apr 2011

Vyteris closes previously announced merger with MediSync BioServices

Vyteris, Inc. today announced that on April 6, 2011, the Company closed on its previously announced agreement to merge with MediSync BioServices, Inc., now a wholly owned subsidiary of Vyteris focused on the potential consolidation of high-value, niche contract research organizations (CRO), site management organizations (SMO) and related businesses within the $22 billion CRO industry.

18 Apr 2011

Baxter enters definitive agreement to acquire Prism

Baxter International Inc. announced today that it has entered into a definitive agreement to acquire privately-held Prism Pharmaceuticals, Inc., a specialty pharmaceutical company based in King of Prussia, PA. Prism Pharmaceuticals has developed and received U.S. Food and Drug Administration (FDA) approval for multiple presentations of NEXTERONE® (amiodarone HCl), an antiarrhythmic agent.

From Baxter International Inc. 18 Apr 2011

Centinel Spine reports record 47% increase in sales for first quarter 2011

A record 47% year-over-year sales increase for Q1, 2011 compared to the same period in 2010 was announced today by Centinel Spine, Inc., innovator and a market leader in the Integrated Interbody Fusion™ spine medical device space.

18 Apr 2011

Tibet Pharmaceuticals' updated online Investor Fact Sheet is now available in China

Tibet Pharmaceuticals, Inc., an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in China, announces the availability of an updated online Investor Fact Sheet.

18 Apr 2011

Edgewater, Haldimand sign deal to acquire supply chain services from SSW

Haldimand War Memorial Hospital and Edgewater Gardens select Shared Services West as its Preferred Supplier for Supply Chain Services.

18 Apr 2011

Amylin reports total revenue of $152.7 million for quarter ended March 31, 2011

Amylin Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2011.

18 Apr 2011

Prism Medical acquires Movement 2

Prism Medical Ltd., a leading provider of durable medical equipment and related services to the mobility disadvantaged, today announced the acquisition of Movement 2 Ltd., a provider of home care patient moving and handling equipment, servicing and repair in the East Midlands region of the UK.

18 Apr 2011

Nuvo Research to acquire ZARS Pharma

Nuvo Research Inc., a pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced that it has entered into an agreement to acquire ZARS Pharma, Inc., a specialty pharmaceutical company based in Salt Lake City, Utah.

18 Apr 2011

Biotech Synergy concludes EP-2101 asset transfer, cancer epitopes related portfolio

Biotech Synergy has concluded the asset transfer of multi-epitope cancer vaccine product formerly known as EP-2101 and cancer epitopes related portfolio. Emile Loria, M.D., former President and Chief Business Officer of IDM and former President & CEO of Epimmune, is the founder of Biotech Synergy.

18 Apr 2011

Health care continues to shine in the U.S. Real Estate Investment Trust world

Health care continues to be a shining star in the U.S. Real Estate Investment Trust world, and with recently announced or closed transactions, public companies' hold on the ever-growing market will continue to soar.

16 Apr 2011

Best Practices develops Market Research Excellence Services for business executives

The Market Research function plays a critical role in helping companies make informed decisions, avoid risk, and uncover opportunities for growth. Although Market Research insights can be vital to corporate success, the function's full value often remains unrealized.

16 Apr 2011